These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2554521)

  • 1. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
    van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
    Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
    España F; Estelles A; Griffin JH; Aznar J
    Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
    Chan AK; Patel S; Male C; Berry LR; Mitchell LG
    Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Lys 62(217) and Lys 63(218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor.
    Shen L; Villoutreix BO; Dahlbäck B
    Thromb Haemost; 1999 Jul; 82(1):72-9. PubMed ID: 10456457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor.
    Van Walderveen MC; Berry LR; Chan AK
    J Biochem; 2010 Aug; 148(2):255-60. PubMed ID: 20538715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against the heparin-dependent protein C inhibitor suitable for inhibitor purification and assay of inhibitor complexes.
    Laurell M; Carlson TH; Stenflo J
    Thromb Haemost; 1988 Oct; 60(2):334-9. PubMed ID: 3217924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
    Marlar RA; Kressin DC; Madden RM
    Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
    Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
    Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.
    Espana F; Zuazu I; Vicente V; Estellés A; Marco P; Aznar J
    Thromb Haemost; 1996 Jan; 75(1):56-61. PubMed ID: 8713780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
    Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
    Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.
    Heeb MJ; Griffin JH
    J Biol Chem; 1988 Aug; 263(24):11613-6. PubMed ID: 3261294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
    Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
    Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.
    España F; Hendl S; Gilabert J; Estellés A; Aznar J
    Thromb Res; 1993 Jun; 70(5):375-84. PubMed ID: 8397450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein.
    Laurell M; Stenflo J
    Thromb Haemost; 1989 Nov; 62(3):885-91. PubMed ID: 2556811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of plasma protein C inhibitor.
    España F; Berrettini M; Griffin JH
    Thromb Res; 1989 Aug; 55(3):369-84. PubMed ID: 2551064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
    Radtke KP; Stief TW; Heimburger N
    Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of plasma protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease.
    España F; Vicente V; Tabernero D; Scharrer I; Griffin JH
    Thromb Res; 1990 Aug; 59(3):593-608. PubMed ID: 2173167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein.
    Kazama Y; Koide T
    Thromb Haemost; 1992 Jan; 67(1):50-5. PubMed ID: 1319617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor.
    Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J
    Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.